Morgan Stanley analyst Aisyah Noor raised the firm’s price target on Medacta Group (MEDGF) to CHF 136 from CHF 135 and keeps an Overweight rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MEDGF: